Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8070578 | 0.75 | ALDH1A1 (0.32) | ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL8074009 | 0.74 | ALDH1A1 (0.31) | ALDH1A1LMNARECQLPOLB | |
| SCHEMBL8075595 | 0.74 | — | — | |
| SCHEMBL10248897 | 0.64 | ALDH1A1 (0.37) | ALDH1A1LMNARECQLTSHRHTT | |
| SCHEMBL681120 | 0.64 | ALDH1A1 (0.37) | ALDH1A1LMNARECQLTSHRHTT | |
| SCHEMBL793443 | 0.64 | ALDH1A1 (0.37) | ALDH1A1LMNARECQLTSHRHTT | |
| SCHEMBL15720375 | 0.63 | ALDH1A1 (0.31) | ALDH1A1LMNARECQLTSHRHTT | |
| SCHEMBL15720476 | 0.63 | ALDH1A1 (0.31) | ALDH1A1LMNARECQLTSHRHTT | |
| SCHEMBL18465132 | 0.63 | — | — | |
| SCHEMBL9853224 | 0.63 | ALDH1A1 (0.32) | ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0410443-A1 | Organosilane compounds | MONTELL NORTH AMERICA INC. (US) | 1991-01-30 | — | — | EP | disclosed |